O B J E C T I V E -This study investigates temporal trends in the prevalence and incidence of persistent proteinuria among people with adult-onset diabetes (age 40 years).
D
iabetes is the largest single cause of end-stage renal disease (ESRD) in the U.S., and the majority of ESRD cases are individuals with adult-onset diabetes (1). There has also been a pro g re ssive and dramatic increase in the incidence of ESRD attributed to diabetes, part i c ularly among elderly patients (1), but the explanation(s) for this is not entire l y known. Possible explanations include i n c reased acceptance and prescription of dialysis for ESRD, increased longevity, and i n c reased prevalence and/or incidence of renal disease in this group. There have been few population-based investigations of secular trends in renal disease among individuals with adult-onset diabetes. A study of Pima Indians with type 2 diabetes found the incidence of pro t e i n u r i a , a marker for the presence of renal disease, increased nearly twofold between 1965 and 1974 and between 1985 and 1994 (2) . The aim of the present study was to d e t e rmine whether there have been changes in the prevalence and/or incidence of persistent proteinuria in a mostly Caucasian population of individuals with adult-onset diabetes.
RESEARCH DESIGN AND METHODS -
The opportunity for population-based studies in Rochester, Minnesota, is the result of an unusual set of circumstances. Rochester is re l a t i v e l y isolated from other population centers and is home to one of the world' s largest tert i a ry care medical centers, the Mayo Clinic. A majority of the medical care received by local residents is pro v i d e d either by the Mayo Clinic, together with its two affiliated hospitals, or a second gro u p practice, Olmsted Medical Center, with its a ffiliated hospital. Since 1907, every Mayo Clinic patient has been assigned a unique i d e n t i f i e r, and all information from every Mayo Clinic contact (including hospital inpatient or outpatient care, office visits, e m e rgency room and nursing home care , as well as death certificate and autopsy i n f o rmation) is contained within a single dossier for each patient. The diagnoses assigned and surgical pro c e d u res per-
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f o rmed at each visit are coded and entere d into continuously updated computer files. With funding from the National Institutes of Health (grant number AR30582), the Mayo Clinic' s indexing system was expanded to include the small number of other providers of care to local re s i d e n t sprimarily the Olmsted Medical Center (3).
Identification of diabetes incidence and prevalence cohorts
The Rochester Epidemiology Project was used to identify all Rochester re s i d e n t s with a diagnosis of diabetes or a diabeteslike condition from 1 January 1945 t h rough 31 December 1989. Complete community medical re c o rds for each potential case, including all laboratory results, were retrieved and reviewed by trained nurse abstractors under the dire ction of an endocrinologist. Diagnostic criteria approximated National Diabetes Data G roup (NDDG) recommendations (4), i.e., two consecutive fasting glucose levels 140 mg/dl or 1-and 2-h levels 2 0 0 mg/dl obtained during a standard oral glucose tolerance test. Using the method of West (5), adjustments were made for temporal changes in laboratory methods. Individuals who failed to meet the above criteria but for whom oral agents or insulin were used for at least 2 weeks or until death also qualified as cases.
The present study took advantage of the previous identification of 1) thre e p revalence groups, i.e., people who were residents of Rochester as of 1 January 1970 1 January , 1980 1 January , or 1990 , and who had met NDDG criteria before the prevalence date, and 2) the 1970-1989 diabetes incidence c o h o rt, consisting of all Rochester re s idents who first met NDDG criteria during that time period (6). The present study was limited to individuals who were age 40 years at the time they met criteria.
Identification of persistent proteinuria
The complete (inpatient and outpatient) medical re c o rds of the above individuals w e re reviewed for evidence of persistent p roteinuria, defined as two or more consecutive urinalyses with grade 1 or gre a t e r p rotein and no subsequent negative values; exceptions were made for patients who had a single negative in a string of positive values and for those who underwent dialysis or transplant. Individuals were followed from their first laboratory urinalysis value in the re c o rd until the last visit, death, or 1 April 1992 (whichever came first). The date 1 April 1992 was selected because a change in re p o rting of ro u t i n e urinalysis protein levels from "trace or grades 1-4" (based on the sulfosalicylic acid method and in use since 1945) to the p rotein/osmolality ratio went into effect 20 April 1992. Vital status and date of death was obtained from medical re c o rds and, if n e c e s s a ry, active telephone and mail foll o w -u p .
Data analysis
The prevalence of persistent pro t e i n u r i a among the 1970, 1980, and 1990 1970, 1980, and 1990 prevalence gro u p s in the pro p o rtion with persistent pro t e i nuria at pre v a l e n c e . The 1970-1989 Rochester diabetes incidence cohort (n = 1,251) was used to estimate the probability that a person had persistent proteinuria before the date they met NDDG criteria, i.e., baseline. To identify secular trends in this pro b a b i l i t y, the significance of baseline calendar year on the likelihood of persistent pro t e i n u r i a was tested using logistic re g re s s i o n , adjusting for age at baseline and sex in the model. The significance of two-way interaction terms and higher order polynomials was examined.
Among diabetes incidence cases fre e of persistent proteinuria at baseline, the subsequent cumulative incidence of persistent proteinuria was estimated using Kaplan-Meier life-table methods (7). To identify secular trends in the incidence of persistent proteinuria, the significance of baseline calendar year was tested using Cox pro p o rtional hazards (8), with age at baseline and sex in the model. Again, the significance of two-way interaction term s and higher order polynomials was examined. Tests for nonpro p o rtionality of haza rds were perf o rmed (9).
S u rvival free of death among members of the 1970-1989 diabetes incidence c o h o rt was assessed using Cox re g re s s i o n (8). The model included sex, baseline calendar year, age and presence of persistent p roteinuria at baseline, and incidence of persistent proteinuria after baseline, e n t e red as a time-dependent covariate. To identify secular trends in the relative risk of mortality associated with persistent pro- Table 1 -Clinical characteristics of members of the 1970, 1980, and 1990 Rochester, M i nnesota, adult-onset diabetes prevalence gro u p s 1 9 7 0 1 9 8 0 1 9 9 0 n 4 4 6 6 4 7 9 4 0 Sex (% male) 4 1 4 7 4 9 Age when NDDG criteria were met (years) M e n 58.8 ± 9.9 57.8 ± 9.8 58.1 ± 10.4 Wo m e n 61.6 ± 10.4 62.6 ± 11.7 61.57 ± 12.0 Age at prevalence (years) M e n 66.4 ± 9.6 66.8 ± 10.2 67.3 ± 10.1 Wo m e n 70.7 ± 10.0 71.9 ± 11.6 71.0 ± 11.9 Duration of diabetes (years) M e n 6.7 ± 5.9 8.0 ± 6.9 8.1 ± 7.0 Wo m e n 8.2 ± 6.6 8.8 ± 6.5 8.7 ± 7.1 Fasting glucose when NDDG criteria were 213 ± 86 208 ± 93 212 ± 84 met (mg/dl) Fasting glucose at prevalence (mg/dl) 171 ± 77 176 ± 70 178 ± 74
Data are means ± SD.
teinuria, the analysis tested for significant interactions between 1) baseline calendar year and prevalence of persistent pro t e i nuria at baseline and 2) baseline calendar year and subsequent incidence of persistent pro t e i n u r i a .
R E S U LT S -Characteristics of the 1970
(n = 446), 1980 (n = 647), and 1990 (n = 940) Rochester diabetes prevalence cases a re summarized in Table 1 . The thre e g roups were similar with respect to fasting glucose at the time they met NDDG criteria and at prevalence. The pro p o rtion of men rose from 41% in 1970 to 49% in 1990; however, in each sex, age at the time they met NDDG criteria and age at pre v alence were similar among the thre e g roups. The number of individuals with persistent proteinuria on or before the p revalence dates was 89 in 1970, 72 in 1980, and 73 in 1990 . The pro p o rt i o n d e c reased from 20% (95% CI 16-24) in 1970 to 11% (8.7-13.6) in 1980 to 8% (6.0-9.5) in 1990 (Fig. 1) . When the analysis was limited to unique observ ations, i.e., people who met NDDG criteria in the 10 years before the prevalence date and there f o re belonged to only one pre v alence group, the pro p o rtions with pre v alent persistent proteinuria were 17, 10, and 5% for 1970, 1980, and 1990 , re s p e ctively (P 0 . 0 0 1 ) . The Rochester diabetes 1970-1989 incidence cohort consisted of 1,251 individuals aged 40 years at the time they met NDDG criteria, i.e., baseline. Characteristics of incidence cases at baseline are c o m p a red for the two time periods 1970-1979 and 1980-1989 in Table 2 . The two incidence cohorts were similar with respect to the pro p o rtion of men, and age and fasting glucose level at baseline. Urinalysis values were unavailable for 1% (n = 11) of individuals. These individuals were excluded from the re m a i n d e r of the analyses. Of the 1,240 individuals, 6% (n = 77) had evidence of persistent p roteinuria on (n = 6) or before (n = 71) baseline. There was a marked decline in this pro p o rtion with increasing baseline calendar year (Fig. 2) . The probability of persistent proteinuria on or before baseline was modeled as a function of age at baseline, sex, and baseline calendar year. The final model is provided in Table 3 . The odds were similar for men and women and increased significantly with age at baseline. After adjusting for age, the odds of having persistent proteinuria on or b e f o re baseline decreased by 50% for each 10-year increase in baseline calendar y e a r. The absence of an interaction between age and calendar year suggests that the effect of calendar year on the odds of persistent proteinuria at baseline was similar for each age.
The 1,163 diabetes incidence cases with no evidence of persistent pro t e i n u r i a at baseline were followed for 8,777 person-years, during which time 136 individuals subsequently developed persistent p roteinuria. The estimated 20-year cumulative incidence was 41% (95% CI 31-59). In Fig. 3 , the cumulative risk of persistent p roteinuria for diabetes cases who met NDDG criteria during 1970-1979 is comp a red with those who met criteria during 1980-1989. Cox pro p o rtional hazard s was used to model the risk of developing persistent proteinuria as a function of age at baseline, sex, and baseline calendar y e a r. Age (per 10-year increment) at baseline was significantly associated with subsequent risk of persistent pro t e i n u r i a (odds ratio 1.52, 95% CI 1.30-1.77, P 0.001); but neither sex nor baseline calendar year was pre d i c t i v e .
S u rvival free of death was modeled using Cox pro p o rtional hazards. The final model (Table 4 ) reveals that incre a s i n g age, male sex, prevalence of persistent proteinuria at baseline, and incidence of persistent proteinuria after baseline were all significantly associated with increased risk of death. Mortality risk decreased with i n c reasing baseline year. The contribution of persistent proteinuria at baseline to m o rtality decreased with increasing age and was greater for women than men. For example, the relative hazard for a 55-yearold woman was 5.6 (95% CI 3.2-9.8) and that for a 55-year-old man was 3.2 (2.0-5.3); that for an 85-year-old woman was 2.4 (1.0-3.5) and that for an 85-yearold man was 1.4 (0.8-2.4). There was no DIABETES CARE, VOLUME 23, NUMBER 1, JANUARY 2000 53
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Figure 1-Proportion of members of the 1970, 1980, and 1990 Rochester, Minnesota, adult-onset diabetes prevalence groups with persistent proteinuria on or before January 1st of the prevalence date. 1 9 7 0 -1 9 7 9 1 9 8 0 -1 9 8 9 n 5 3 6 7 1 5 Sex (% male) 4 9 5 1 Age at baseline* (years) M e n 61.7 ± 11.2 62.4 ± 11.0 Wo m e n 65.8 ± 12.5 65.1 ± 12.8 Fasting glucose at baseline* (mg/dl) 217 ± 94 218 ± 87
Data are means ± SD. *Baseline is the date NDDG criteria were met.
Prevalence group significant interaction between baseline calendar year and either 1) the pre v a l e n c e of persistent proteinuria at baseline or 2) the incidence of persistent pro t e i n u r i a after baseline, suggesting that there was no secular trend in the relative risk of mort a lity associated with persistent pro t e i n u r i a .
CONCLUSIONS -This study revealed that the pro p o rtion of adult-onset diabetes prevalence cases with persistent p roteinuria on or before the pre v a l e n c e date decreased from 20% in 1970 to 11% in 1980 and 8% in 1990 in the Rochester, Minnesota, population. The decline was accompanied by a secular decline in the p ro p o rtion of adult-onset diabetes incidence cases who had persistent pro t e i nuria on or before the date they met NDDG criteria (i.e., baseline) over the time period of 1970-1989. There was no secular tre n d in either the incidence of proteinuria after baseline or the effect of persistent pro t e i nuria on mort a l i t y. The absence of a secular trend in the risk of persistent proteinuria after baseline is similar to a previous re p o rt fro m Rochester in which Ballard et al. (10) found no secular trend in the incidence of persistent proteinuria among individuals who met criteria for type 2 diabetes between 1945 and 1968. The temporal decline in the prevalence of persistent proteinuria at or before baseline among diabetes incidence cases in the present study is also consistent with combined observ ations from two previous Rochester studies (10,11). Ballard et al. (10) found that 8.2% of the 1945-1969 type 2 diabetes incidence cohort had persistent proteinuria at or before they met criteria for diabetes. This compares with 7.2% found by H u m p h rey et al. (11) in their review of the Rochester cohort updated through 1979. The overall prevalence of persistent proteinuria at baseline among members of the 1970-1989 adult-onset diabetes incidence c o h o rt in the present study was 6%. Dire c t comparisons of our study findings with those of Ballard et al. and Humphrey et al. is difficult, however, because of diff e re n c e s in diabetes case criteria. The two pre v i o u s studies focused on type 2 diabetes, including all ages, rather than on individuals aged 40 years, and the threshold for fasting glucose in those studies was 120 mg/dl rather than the 140 mg/dl threshold used in this study.
Comparison of the present study with non-Rochester studies is even more pro blematic. Among nondiabetic populations, the overall prevalence of proteinuria has been re p o rted to vary between 2 and 15% (12,13). This wide range is likely related to d i ff e rences in the risk of nephro p a t h y among diff e rent populations as well as methodological diff e rences in the determ ination and definition of proteinuria. In studies that focus on people with adultonset diabetes, diff e rences in the definition of diabetes and in the time in the course of disease at which protein is measured contribute to even greater discrepancies in the p revalence of persistent proteinuria, with estimates ranging from 2 to 46% (13-19).
The estimated cumulative incidence of persistent proteinuria in the pre s e n t study was 12% at 10 years and 41% at 20 years. This incidence compares with a cumulative incidence at 20 years of 25% re p o rted by Ballard et al. (10) in the earlier Rochester study. The lower estimate by B a l l a rd et al. is again due in part to the inclusion of younger subjects with milder diabetes in their study. Klein et al. (20) found a 10-year cumulative incidence of p roteinuria (defined as urine protein concentration 0.3 g/l, as measured by a reagent strip) among Wisconsin re s i d e n t s with older-onset diabetes of 33-40%, depending on treatment type. The higher incidence in the study by Klein et al. is p a rtly because Klein et al. enrolled pre v alence cases (with diabetes duration ranging from 0 to 30 years), and follow-up began at enro l l m e n t .
To our knowledge, the only other population-based investigation of re c e n t secular trends in persistent pro t e i n u r i a among individuals with adult-onset diabetes is the study among Pima Indians by Nelson et al. (2), which revealed a marked i n c rease in the cumulative incidence of p roteinuria between people diagnosed with type 2 diabetes during 1965-1974 and those diagnosed during 1985-1994 . The marked contrast between the findings of Nelson et al. and those re p o rt e d h e re may be due in part to diff e rences in methodology (diabetes in the Pima Indian study was defined based on systematic oral glucose tolerance tests; pro t e i n u r i a was defined based on systematic prot e i n / c reatinine ratios) but is also likely
54
DIABETES CARE, VOLUME 23, NUMBER 1, JANUARY 2000
Proteinuria trends in diabetes
F i g u re 2-P ro p o rtion of members of the 1970-1974, 1975-1979, 1980-1984, and 1985-1989 Rochester, Minnesota, adult-onset diabetes incidence cohorts with persistent proteinuria on or before the date they met NDDG criteria. due to major diff e rences between study populations (Rochester is 95% white). C o m p a red with primarily Caucasian populations, Pima Indians are characterized by earlier age of onset of diabetes, a much higher rate of renal disease, and a higher p ro p o rtion of renal disease that is attributable to diabetes (2, 19, 21, 22) . Caucasian populations also differ from both diabetic and nondiabetic Pima Indians with respect to recent secular trends in causespecific mortality (23).
One potential explanation for the secular decline in the prevalence of persistent p roteinuria in the present study is that diabetes was detected earlier in more re c e n t time periods. We cannot completely exclude this possibility, but the absence of any secular trend in either mean age or fasting glucose concentration pro v i d e s i n d i rect evidence that the decline in the p revalence of persistent proteinuria was not due to earlier detection of diabetes in m o re recent years. Also, if the decline in p revalence of persistent proteinuria at baseline among diabetes incidence cases was an artifact of earlier detection of diabetes, one might expect to see a temporal i n c rease in the incidence of pro t e i n u r i a after baseline or evidence of nonpro p o rtional hazards in the survival analysis. Neither was found.
Another possible explanation for the decline in the pro p o rtion of people with adult-onset diabetes who have persistent p roteinuria on or before baseline is a change in the prevalence of pro t e i n u r i a among the general population-diabetic and nondiabetic alike; we are pre s e n t l y unable to address this issue. Finally, a recent pilot study of temporal trends in h y p e rtension and treatment for hypert e nsion among members of the 1970-1989 Rochester diabetes incidence cohort suggests that the decline in the prevalence of persistent proteinuria was not accompanied by improved control of hypert e nsion. Pre l i m i n a ry results from a random sample of 400 cases showed that the prop o rtion of people with two outpatient blood pre s s u re readings 140/90 mmHg at baseline (± 2 years) was unchanged, despite a slight but insignificant incre a s e in the pro p o rtion of cases treated for h y p e rtension between 1970 and 1989 (24) . This latter finding is intriguing in light of clinical trial results showing certain antihypertensive medications introduced over this time period aff o rd i n t r a renal arteriolar effects beyond just c o n t rol of systemic hypertension for diabetic renal disease (25). There f o re, it will be important to determine whether declines in the prevalence of persistent p roteinuria were accompanied by incre a sing use of ACE inhibitors.
T h e re are several limits to the pre s e n t s t u d y. The Rochester population is comprised largely of middle-class Caucasians of nort h e rn European ancestry, so these results cannot necessarily be extrapolated to the general population of the U.S. Another limitation is that, although the method of measuring proteinuria was consistent, the frequency and timing of urinalysis was not. The presence of persistent p roteinuria was based on urinalysis samples obtained during routine medical care and not on 24-h urine total protein meas u rements. Proteinuria based on random samples is semiquantitative, and a positive result may not always re p resent clinically significant proteinuria. Cases of transiently i n c reased proteinuria were excluded, however, because the present study defined persistent proteinuria as two or more cons e cutive urinalyses with grade 1 or gre a t e r p rotein and no subsequent negative values. Among individuals who had two consecutive values, those who emigrated or died were considered a case, where a s those who survived and acquired additional negative values were not considere d a case. This distinction could account for the observed secular decline in the pre v alence of persistent proteinuria on or before baseline if the opportunity to acquire subsequent negative values was greater for people who met NDDG criteria in re c e n t years relative to those who met it earlier. [1970] [1971] [1972] [1973] [1974] [1975] [1976] [1977] [1978] [1979] [1980] [1981] [1982] [1983] [1984] [1985] [1986] [1987] [1988] [1989] Rochester, Minnesota, adult-onset diabetes incidence cohort who were free of persistent proteinuria at the time they met NDDG criteria. , Individuals who met criteria in 1970-1979 (n = 483); , individuals who met criteria in 1980-1989 (n = 680) . 
